DRA

Vantaa, Finland Founded: 2002 • Age: 24 yrs Acquired By PharmaLex
Market access services are provided to the biopharma sector.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About DRA

DRA is a company based in Vantaa (Finland) founded in 2002 was acquired by PharmaLex in August 2022. DRA offers products and services including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services. DRA operates in a competitive market with competitors including OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.

  • Headquarter Vantaa, Finland
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Pharmalex Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    PharmaLex

    (Aug 26, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DRA

DRA offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.

Product name locked
Category locked
Primary

Provides strategic advice for pharmaceutical development and innovation.

Product name locked
Category locked
Locked

Manages adverse event monitoring and risk assessment in healthcare.

Product name locked
Category locked
Locked

Handles regulatory writing and agency interactions for approvals.

Funding Insights of DRA

Premium access

Detailed funding history for DRA

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in DRA

DRA has secured backing from 1 investor. Prominent investors backing the company include PharmaLex.

All
Investor Description Founded Year Domain Location
CRO specializing in regulatory affairs and pharmacovigilance
Locked Locked Locked
Premium access

Investor details for DRA

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DRA

Investments
Premium access

Investment portfolio details for DRA

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - DRA

Premium access

Detailed financials for DRA

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Dra Comparisons

DRA Primary company
Description
Market access services are provided to the biopharma sector.
Location
Vantaa, Finland
Founded Year
2002
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for DRA

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of DRA

DRA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of healthcare marketing services
Locked Locked Locked
Marketing services to the pharmaceutical industry are provided.
Locked Locked Locked
Consulting services for market access, health economics and outcomes research
Locked Locked Locked
Consulting services for market access and health outcomes are provided.
Locked Locked Locked
Healthcare data analytics services provider
Locked Locked Locked
Offers business insurance, employee benefits, and risk consulting services worldwide.
Premium access

Detailed competitors of DRA

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Dra

Premium access

Complete news archive for DRA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DRA

DRA was founded in 2002.

DRA is headquartered in Vantaa, Finland.

DRA was established in 2002 and is based in Vantaa, Finland. Market access services are delivered to companies in the biopharma industry. Operations focus on supporting product launches, pricing strategies, and reimbursement processes. Expertise is applied across European markets, with emphasis on regulatory compliance and stakeholder engagement. The domain dra.fi serves as the primary online presence for these activities.

DRA's top competitors include OPEN Health, Abacus Medicine and Target RWE.

DRA offers Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.

DRA has 1 investor. Key investors include PharmaLex.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available